Aspen gets R531m funding to develop vaccines
--:--
Stavros Nicolaou – Senior Executive: Strategic Trade Development, Aspen
Pharmacare Group
Pharmacare Group
Other recent episodes
[FULL SHOW] GNU on tenterhooks, asset management transformation and SA’s debt
This evening we look at the markets with Sasfin Wealth, we speak to Gibs about volatility surrounding the GNU’s budget vote, Novare gives us insight into transformation in the local asset management industry, Absa helps us rethink SA’s debt, and we get to know Sun International’s outgoing CEO Anthony Leeming,…
Market Watcher: Anticipation is more than the event
Sasfin's David Shapiro runs us through the day's market developments, anticipating Trump's 'liberation day', consumer sentiment, US markets reflecting uncertainty, the rand taking on weakness from local politics, and market fatigue.
Is Vat the straw that breaks the GNU’s back?
Adrian Saville – Professor: Economics, Finance and Strategy, Gibs
Executive Lounge: Sun International CEO officially leaves his key at reception
Anthony Leeming – Outgoing CEO, Sun International
Rethinking SA’s debt market
Chetan Jeeva – Head: SA Debt, Absa CIB